COMMUNIQUÉS West-GlobeNewswire

electroCore to Announce Fourth Quarter and Year Ended December 31, 2018 Financial Results on Wednesday, March 27
18/03/2019
Conference Call to be Held at 4:30pm Eastern Time BASKING RIDGE, N.J., March 18, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that it will [...]
Dynavax Exercises Option for $75 Million in Non-Dilutive Debt
18/03/2019
Proceeds to fund HEPLISAV-B® commercialization activities and completion of ongoing immuno-oncology studies BERKELEY, Calif., March 18, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ: DVAX) today [...]
IRIDEX to Present at the Spring Investor Summit
18/03/2019
MOUNTAIN VIEW, Calif., March 18, 2019 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the Company plans to present at the upcoming Spring Investor Summit in New York, NY. Chairman and CEO William [...]
Organogenesis Holdings Inc. Reports Fourth Quarter and Fiscal Year 2018 Financial Results
18/03/2019
CANTON, Mass. , March 18, 2019 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions [...]
Novavax Reports Fourth Quarter and Year-End 2018 Financial Results
18/03/2019
Company to Host Conference Call Today at 4:30 p.m. ET GAITHERSBURG, Md., March 18, 2019 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX) today announced its financial results and operational highlights for the fourth [...]
HealthEquity Reports Fourth Quarter and Fiscal Year Ended January 31, 2019 Financial Results
18/03/2019
Highlights of the fiscal year include: Revenue of $287.2 million, an increase of 25% compared to FY18. Net income of $73.9 million, an increase of 56% compared to FY18. Net income per diluted share of $1.17, compared to [...]
Evolus Reports Fourth Quarter and Full Year 2018 Results
18/03/2019
Received U.S. FDA Approval of Jeuveau™ on February 1, 2019 Majority of Sales Force Hired with Launch Planned in the Coming Weeks Hosting Investor & Analyst Day on May 8 th , 2019 in New York, NY NEWPORT BEACH, Calif [...]
CohBar Reports Fourth Quarter 2018 Financial Results and Provides Business Update
18/03/2019
MENLO PARK, Calif., March 18, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related diseases, today reported [...]
Evolus Secures $100 Million Senior Debt Facility with Oxford Finance LLC
18/03/2019
Provides Non-Dilutive Financing and Increased Flexibility Ahead of Jeuveau™ U.S. Launch NEWPORT BEACH, Calif., March 18, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer [...]
iCAD Reports Fourth Quarter and Full-Year 2018 Financial Results
18/03/2019
Company achieved key milestone in fourth quarter with FDA clearance and subsequent U.S. commercial launch of ProFound AI™ for digital breast tomosynthesis Conference call today at 4:30 p.m. ET NASHUA, N.H. , March 18, [...]
resTORbio Reports Fourth Quarter and Full Year 2018 Financial Results
18/03/2019
Positive End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA); Phase 3 program of RTB101 expected to initiate in 2Q19 Phase 1b/2a trial of RTB101 in combination with sirolimus in Parkinson’s disease ( [...]
Cytokinetics Announces Presentation of Additional Results From COSMIC-HF at ACC.19
18/03/2019
No Difference in Treatment Effects of Omecamtiv Mecarbil in Patients with Heart Failure Irrespective of Atrial Fibrillation SOUTH SAN FRANCISCO, Calif., March 18, 2019 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated ( [...]
IntelGenx to Report Fourth Quarter and Full-Year 2018 Financial Results on March 25, 2019 – Conference Call to Follow
18/03/2019
SAINT LAURENT, Quebec, March 18, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX VENTURE:IGX)(OTCQX:IGXT) today announced that it will release its fourth quarter and full year 2018 financial results after [...]
B. Braun Showcases Clinical Nutrition Portfolio at ASPEN 2019 Nutrition Science & Practice Conference
18/03/2019
BETHLEHEM, Pa., March 18, 2019 (GLOBE NEWSWIRE) -- B. Braun Medical Inc., a leader in customized parenteral nutrition, will exhibit their Clinical Nutrition portfolio at this year’s American Society for Parenteral and [...]
Amphera Recruits First Patients to Pivotal Phase II/III study of MesoPher to Treat Pleural Mesothelioma
18/03/2019
Proprietary immuno-oncology approach harnesses autologous dendritic cell therapy to treat an orphan-designated cancer `s-Hertogenbosch, The Netherlands, March 18, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Amphera B.V [...]
DiaMedica Therapeutics Announces Date for the Release of Full Year 2018 Results and Conference Call
18/03/2019
MINNEAPOLIS, March 18, 2019 (GLOBE NEWSWIRE) -- DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that its 2018 financial results will be released after market close on Tuesday, March 19th. DiaMedica’s [...]
Virbac: 2018 operating profit from ordinary activities grew by 13.4%
18/03/2019
Virbac: 2018 operating profit from ordinary activities grew by 13.4% CONSOLIDATED DATA AS OF DECEMBER 31 st in € million 2018 2017 % change 2018/2017 Revenue from ordinary activities 868.9 861.9 +0.8 % Evolution at [...]
Virbac : résultat opérationnel courant 2018 en croissance de +13,4%
18/03/2019
Virbac : résultat opérationnel courant 2018 en croissance de +13,4% CHIFFRES CONSOLIDÉS AU 31 DÉCEMBRE en millions € 2018 2017 Évolution 2018/2017 Chiffre d’affaires 868,9 861,9 +0,8 % Évolution à taux de change [...]
Ossur Hf : Transactions in relation to share buyback program
18/03/2019
Announcement no. 19/2019 18 March 2019 Transactions in relation to share buyback program On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the share [...]

Pages